Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine thioethers in neurodegeneration.

K R Sidell1, V Amamath, T J Montine

  • 1Department of Pathology and Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Current Topics in Medicinal Chemistry
|March 16, 2002
PubMed
Summary

Oxidized dopamine metabolites, specifically 5-S-cysteinyldopamine (Cys-DA), are elevated in advanced Parkinson's disease (PD) and may disrupt dopamine (DA) trafficking, contributing to neurodegeneration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies.

Molecular psychiatry·2017
Same author

Characterization of cognitive impairments and neurotransmitter changes in a novel transgenic mouse lacking Slc10a4.

Neuroscience·2016
Same author

Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.

Parkinsonism & related disorders·2015
Same author

A novel Alzheimer disease locus located near the gene encoding tau protein.

Molecular psychiatry·2015
Same author

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Nature genetics·2013
Same author

Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques.

Neurology·2010

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Dopamine oxidation is implicated in mesostriatal neurodegeneration.
  • Mercapturic acid pathway (MAP) metabolites of oxidized dopamine (DA) may play a role.
  • 5-S-cysteinyldopamine (Cys-DA) is elevated in advanced Parkinson's disease (PD).

Purpose of the Study:

  • To review findings on MAP enzymes and their products in neurodegeneration.
  • To investigate the neurobiological activity of MAP metabolites of oxidized DA.
  • To determine the role of Cys-DA in dopamine (DA) trafficking and PD.

Main Methods:

  • Review of recent findings on MAP enzymes and products in rodent and human brain tissue.
  • Analysis of neurobiological activity of MAP metabolites of oxidized DA in vitro and in vivo.

Related Experiment Videos

  • Comparison of MAP product levels in PD patients with varying disease severity.

    • Main Results:

    • Human striatum exhibits limited enzymatic capacity for mercapturate formation.
    • MAP products of oxidized DA are significantly elevated in advanced PD but not mild PD.
    • Cys-DA interferes with dopamine (DA) trafficking both in vitro and in vivo.

    Conclusions:

    • Cys-DA may disrupt dopamine (DA) trafficking in patients with advanced dopaminergic neurodegeneration.
    • Elevated MAP metabolites are linked to severe PD, suggesting a role in disease progression.
    • Further research is needed to fully elucidate the mechanisms of dopamine (DA) neurodegeneration.